临床试验/NCT01394666

NCT01394666已完成不适用

Treatment Patterns and Associated Outcomes in Chronic Phase (CP) Chronic Myelogenous Leukemia (CML) Patients Who Fail Imatinib 400 mg Daily

Bristol-Myers Squibb0 个研究点目标入组 150 人开始时间: 2011年5月最近更新: 2016年7月11日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方
入组人数: 150
主要终点: Complete Cytogenic Response (CCyR) for CP-CML patients who failed Imatinib 400 mg daily

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to evaluate treatment patterns and associated outcomes for CP-CML patients who fail Imatinib 400 mg daily in a real-world setting.

详细描述

Time Perspective: Retrospective and Prospective

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Retrospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Adult patients (18 years or older) in Chronic phase CML patients who have been treated with Imatinib 400 mg and have failed.

排除标准

未提供

结局指标

主要结局

Complete Cytogenic Response (CCyR) for CP-CML patients who failed Imatinib 400 mg daily

时间窗: At 12 months post treatment change

次要结局

Prognostic factors (clinical and demographic characteristics) that influence treatment selection for CP-CML patients who fail imatinib 400 mg daily(12 months after start of treatment)
Best response rates achieved by patients if no CCyR(12 months after start of treatment)

研究者

发起方

Bristol-Myers Squibb

申办方类型

Industry

责任方

Sponsor

相似试验

已完成

不适用

A Retrospective Study of Treatment Patterns and Clinical Outcomes in Patients With Central Nervous System TuberculosisCentral Nervous System Tuberculosis

NCT06011915Tongji Hospital638

已完成

不适用

A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque PsoriasisPsoriasis

NCT05547490Bristol-Myers Squibb3,506

已完成

不适用

Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From IndiaLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Mantle-Cell

NCT03476655Johnson & Johnson Private Limited40

已完成

不适用

Study Conducted Among Patients With CMLChronic Myeloid Leukemia

NCT05476562Novartis Pharmaceuticals3,234

已完成

不适用

A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-WorldLeukemia, Myeloid, Acute

NCT04337138Pfizer32